SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending as shareholders react to a recent FDA warning letter and subsequent class-action lawsuit filings, fueling intense debate between long-term investors focused on global expansion and short-term traders concerned about volatility. The community is actively weighing the potential for international revenue from Saudi Arabia and Europe against concerns regarding domestic regulatory hurdles, while discussing whether the current price action represents a buying opportunity or a deeper correction.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is trending due to significant overnight volatility triggered by conflicting reports regarding a potential wind-down of the Iran conflict, sparking intense debate among investors about the durability of the current market pump. Community sentiment remains polarized, with many traders labeling the rally a "fake" move or a bull trap, while others are closely monitoring technical levels and geopolitical developments for signs of a more sustainable relief rally.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The Invesco QQQ Trust is trending as traders navigate extreme volatility fueled by uncertainty over the U.S. military presence in Iran and fluctuating oil prices. Community sentiment is deeply divided, with many market participants actively debating the impact of geopolitical news leaks on price action while cautioning one another about potential bull traps amidst the ongoing market instability.

Spdr Dow Jones Industrial Average ETF Trust - Units of undivided interest in DIAMONDS Trust Series 1

The SPDR Dow Jones Industrial Average ETF (DIA) is currently at the center of market volatility as investors weigh conflicting reports over the potential resolution of the U.S. military campaign in Iran. While some traders are reacting to speculative optimism regarding a diplomatic wind-down, the community remains deeply divided, with many debating the impact of energy supply disruptions and the sustainability of market rallies amidst persistent geopolitical uncertainty.

Maul Coin

Maul Coin is currently trending as community members rally to push the token toward a bonding curve completion while advocating for broader platform visibility and a price surge. Supporters are actively engaging on social platforms to build organic momentum, framing the project as a community-driven alternative to other memecoins and larger market volatility.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy (MULN) is trending as retail investors engage in a polarized debate over its transition into the crypto space, with some community members promoting it as a community-driven project while many others dismiss it as a continuation of previous stock-based manipulation schemes. Sentiment remains heavily divided, with vocal critics highlighting past dilution and reverse splits, while optimistic supporters focus on its potential as a grassroots movement.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is generating significant buzz as traders capitalize on rising lithium prices and positive sentiment around the company's operational growth, with many investors closely monitoring potential short squeezes and high call volume. Community sentiment is largely focused on the long-term potential of the sector driven by energy storage demands, though some remain cautious due to the stock's historical volatility and the presence of activist short sellers.

iShares Trust - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The Russell 2000 ETF (IWM) is trending as traders closely monitor geopolitical tensions in the Middle East, specifically weighing conflicting signals regarding U.S. military operations against Iran and potential ceasefire negotiations. The community is actively debating the reliability of recent official statements, with many investors focused on how these developments will influence energy prices, interest rate expectations, and broader market volatility as traders look for signs of a sustainable floor.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently drawing intense market attention as traders navigate a high-volatility environment driven by rumors regarding a potential SpaceX IPO and broader geopolitical tensions. Community sentiment is deeply polarized, with active debates centered on whether the stock's premium valuation is justified by its long-term technological disruption or if it remains vulnerable to fundamental headwinds and speculative selling pressure.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is trending as investors digest a major business model shift toward selling proprietary data center CPUs alongside its traditional IP licensing, with Meta named as a marquee customer. The stock is seeing significant volatility as market participants debate whether this expansion into hardware justifies its rich valuation, with the community actively monitoring technical support levels while tracking the broader impact on the semiconductor landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CareDx (NASDAQ:CDNA) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell?

CareDx (NASDAQ:CDNA) Shares Cross Below 200-Day Moving Average - Time to Sell...

Fred Alger Management LLC Sells 304,736 Shares of CareDx, Inc. $CDNA

Fred Alger Management LLC trimmed its position in CareDx, Inc. (NASDAQ:CDNA - Free Report) by 24.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities...

Bamco Inc. NY Has $45.88 Million Stake in CareDx, Inc. $CDNA

Bamco Inc. NY grew its stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) by 29.5% during the third quarter, according to the company in its most recent disclosure with the Securities and...

Braidwell LP Makes New Investment in CareDx, Inc. $CDNA

Braidwell LP purchased a new position in CareDx, Inc. (NASDAQ:CDNA - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange...

CareDx, Inc. $CDNA Shares Purchased by ArrowMark Colorado Holdings LLC

ArrowMark Colorado Holdings LLC raised its stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) by 34.4% during the third quarter, according to its most recent filing with the Securities and...

Portolan Capital Management LLC Grows Stake in CareDx, Inc. $CDNA

Portolan Capital Management LLC raised its stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) by 48.2% in the third quarter, according to the company in its most recent 13F filing with the...

CareDx Introduces VANTx AI Platform for Complex Transplant Datasets

CDNA launches VANTx, an AI-driven cloud platform that turns complex transplant datasets into insights to support clinical research and real-world evidence.

CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference

CareDx (NASDAQ:CDNA) executives outlined the company's transplant-focused strategy, recent financial performance, and 2026 priorities during remarks at the Raymond James Institutional Investor...

CareDx, Inc. (NASDAQ:CDNA) Given Consensus Rating of "Hold" by Analysts

CareDx, Inc. (NASDAQ:CDNA - Get Free Report) has received an average recommendation of "Hold" from the nine research firms that are covering the firm, MarketBeat.com reports. One investment analyst...

CareDx Announces VANTx, an AIPowered Clinical Data & Analytics Platform Built on CareDxs Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets

CareDx, Inc. (Nasdaq: CDNA) The Transplant Company, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, highvalue...

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Caredx Inc

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

CDNA
Caredx Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CDNA News

CDNACaredx Inc